JTC-801 Catalog No.:M10699-2 Preclinical studies demonstrated that AMG

Preclinical studies demonstrated that AMG 837 was a potent GPR40 partial agonist which lowered post-prandial glucose levels

13(5):282-290

01) and the total time spent in EEG seizure activity by 30 to 50% (p<0

Molecular Weight: 806

Molecular Weight: 366

JTC-801 Catalog No.:M10699-2 Preclinical studies demonstrated that AMGJTC 801 is an opioid analgesic drug used in scientific research. JTC 801 is a selective antagonist for the nociceptin receptor, also known as the ORL 1 receptor. The noiciceptin receptor has complex effects which are involved in many processes involved in pain and inflammation responses, and activation of this receptor can either increase or reduce pain depending on dose. Drugs acting at the noiciceptin receptor may influence the effects of